FASN inhibition as a potential treatment for endocrine-resistant breast cancer-Reference-Cited by-同舟云学术

FASN inhibition as a potential treatment for endocrine-resistant breast cancer

Published:2021-04-24 Issue: Volume: Page:
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Gruslova Aleksandra,McClellan Bryan,Balinda Henriette U.,Viswanadhapalli Suryavathi,Alers Victoria,Sareddy Gangadhara R.,Huang Tim,Garcia Michael,deGraffenried Linda,Vadlamudi Ratna K.,Brenner Andrew J.^ORCID

Funder

National Cancer Institute

Kolitz Family Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06231-6.pdf

Reference39 articles.

1. Menendez J, Lupu R (2017) Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells. Oncogenesis 6(2):e299–e299

2. Robertson JF et al (2016) Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. The Lancet 388(10063):2997–3005

3. Lupu R, Menendez JA (2006) Targeting fatty acid synthase in breast and endometrial cancer: an alternative to selective estrogen receptor modulators? Endocrinology 147(9):4056–4066

4. Dickler MN et al (2017) MONARCH 1, a phase II study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2− metastatic breast cancer. Clin Cancer Res 23(17):5218–5224

5. Hortobagyi GN et al (2016) Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med 375(18):1738–1748

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-nuclear and cytoplasmic steroid receptor signalling in hormone dependent cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses;Translational Oncology;2024-07

3. Targeting aberrant fatty acid synthesis and storage in endocrine resistant breast cancer cells;2024-06-03

4. The lipid metabolism remodeling: A hurdle in breast cancer therapy;Cancer Letters;2024-02

5. Identification and verification of anoikis-related gene markers to predict the prognosis of patients with bladder cancer and assist in the diagnosis and treatment of bladder cancer;Translational Cancer Research;2024-02